Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim injunction imposed by a single judge […]
Reportedly, on an appeal filed by Cipla pertaining to COPD drug INDAFLO, the Delhi High court division bench maintained the interim injunction imposed by a single judge […]
An enforceable Patent being the key to effective Commercialization/Out-Licensing of any technology needs to be drafted well. No matter how good a technology is, if the description […]
India, though in a phase of rapid economic development, still has the bane of poverty. In this country, around 22% of the population is below the Poverty […]
An attempt to analyze the case study related to section 3 (k) of Patent Act, 1970 as follows: Accenture Global Service GMBH (Appellants) Vs Assistant Controller of […]
This article focuses on the revocation proceedings which is one of the mechanisms available for annulations of Patents in India. 1. What is the revocation of a […]
Ms. Sakshi Jhalani, Intern, Khurana & Khurana, Advocates, and IP Attorneys looks into the fundamentals of Comparative Advertisement vis-a-vis Trade Mark Rights in India. Advertising is indeed […]
Union budget that was highly waited for (after demonetization) had gained more attention also due to preponing to February 01, 2017. As a matter of fact, every […]
“A start-up would now require only a certificate of recognition from the Department of Industrial Policy and Promotion (DIPP) and would not be required to be examined […]
In Teva Parenteral Medicines, Inc.; APP Pharmaceuticals LLC; Pliva Hrvatska D.O.O.; Teva Pharmaceuticals USA, Inc.; and Barr Laboratories, Inc. (hereinafter referred to be as Defendants/Appellants/Teva) Vs. Eli […]
With effect from May 16, 2016 (effective date for Patent (amendment) rules, 2016), the provision of the expedited examination was introduced in the Patent system of India. […]